• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Li Wang, MA, PhD

Latest:

Thromboembolism Prophylaxis in Medical Inpatients: Effect on Outcomes and Costs

VTE prophylaxis is underutilized in medical patients in US hospitals, but the occurrence of VTE has a major clinical and economic impact.



Mitesh S. Patel, MD, MBA, MS

Latest:

Patient and Physician Predictors of Hyperlipidemia Screening and Statin Prescription

Physician and patient predictors of hyperlipidemia screening and statin prescription at a large, multihospital regional health center based on electronic health record data.




Michael L. Millenson, BA

Latest:

Patient-Centered Care: Turning the Rhetoric Into Reality

Understanding the perspectives of clinicians and administrators who are leaders in implementing patient-centeredness in accountable care organizations can help point the way toward implementation by others.


Roy H. Perlis, MD, MSc

Latest:

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings

Pharmacy and medical claims data showed that patients whose clinicians had access to pharmacogenetic test results had increased adherence and overall cost savings.



John E. Kralewski, PhD

Latest:

Is Patient Satisfaction Influenced by the Intensity of Medical Resource Use by Their Physicians?

Patient satisfaction does not seem to be influenced by the intensity of medical resource use by their physicians.



Jonathan Raviotta, MPH

Latest:

Cost-Effectiveness of a Statewide Falls Prevention Program in Pennsylvania: Healthy Steps for Older Adults

“Healthy Steps for Older Adults,” the Pennsylvania Department of Aging’s falls prevention program, resulted in savings of $718 to $840 per person.


Eli Krantman, MD

Latest:

Low Clinical Utility of Folate Determinations in Primary Care Setting

It seems that folate determinations in patients without known risk factors for folate deficiency are of little clinical significance.







Daniel B. Smith, MA

Latest:

Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data Analysis

Out-of-pocket payments differ widely among oral oncolytic options. As cost for therapy becomes a greater part of treatment decisions, an understanding of patient out-of-pocket cost will be critical in informing choices.



Paul Wicks, PhD

Latest:

Partnering With Patients to Rapidly Develop a Quality-of-Life Measure in Mycosis Fungoides/Sézary Syndrome Type Cutaneous T-cell Lymphoma

The field of measurement in Mycosis Fungoides/Sézary syndrome type cutaneous T-cell lymphoma lacked a specific quality-of-life measure to describe patient experience or guide treatment decisions. Using an online platform with an engaged patient community, we developed and psychometrically validated a new measure in just under a year.


Knashawn H. Morales, ScD

Latest:

Measuring Concurrent Oral Hypoglycemic and Antidepressant Adherence and Clinical Outcomes

Self-reported adherence tended to overestimate medication adherence compared with electronic monitoring. Electronic monitoring of oral hypoglycemic agents but not self-reported adherence predicted glycemic control.



Dylan Supina, PhD

Latest:

Analysis of Venous Thromboprophylaxis Duration and Outcomes in Orthopedic Patients

Extended-duration thromboprophylaxis (>14 days) for total hip replacement/total knee replacement was associated with significantly lower risk for thromboembolic and bleeding events than short-duration thromboprophylaxis.





Kimberly Lovett Rockwell, MD, JD

Latest:

Incorporating Telemedicine as Part of COVID-19 Outbreak Response Systems

Healthcare providers should revisit disaster response policies to incorporate telemedicine systems to address some of the unique challenges posed by infectious disease outbreaks such as coronavirus disease 2019 (COVID-19).


Josh J. Carlson, PhD

Latest:

Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and Prospects

Assessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.


Akshay S. Desai, MD, MPH

Latest:

Future Treatment Approaches in Heart Failure

Panelists discuss their excitement about the evolution of heart failure as a distinct specialty with multiple effective therapeutic options, the convergence of previously siloed medical disciplines around shared evidence-based therapies that treat root causes of multiple comorbidities, and emerging technologies like clinical decision support systems and remote patient monitoring to improve population health management and prevent hospitalizations.


© 2025 MJH Life Sciences
AJMC®
All rights reserved.